Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation

Simple item page
dc.contributor.authorShukla, Nikhil A.
dc.contributor.authorHanna, Nasser H.
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2020-06-24T16:32:35Z
dc.date.available2020-06-24T16:32:35Z
dc.date.issued2020-03
dc.eprint.versionFinal published versionen_US
dc.identifier.citationShukla, N. A., & Hanna, N. H. (2020). Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation. Lung cancer management, 9(1), LMT23. https://doi.org/10.2217/lmt-2020-0001en_US
dc.identifier.urihttps://hdl.handle.net/1805/23073
dc.language.isoen_USen_US
dc.publisherFuture Medicineen_US
dc.relation.isversionof10.2217/lmt-2020-0001en_US
dc.relation.journalLung Cancer Managementen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourcePMCen_US
dc.subjectCheckpoint inhibitorsen_US
dc.subjectChemoradiationen_US
dc.subjectLung canceren_US
dc.titlePractical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiationen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
lmt-09-25.pdf
Size:
502.2 KB
Format:
Adobe Portable Document Format
Description:
Main article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Medicine Works